Drug resistance in ovarian cancer: from mechanism to clinical trial
Ling Wang(Chongqing University), Dongling Zou(Chongqing Cancer Hospital), Xin Wang(Shandong Provincial Hospital), Haixia Wang(Zhejiang University of Technology), Qiaoling Li(China National Rice Research Institute), Xueping Zhu(Chongqing University), Lin Zhong(Chongqing University), Qin Tang(Chongqing University), Qingxiu Jiang(Chongqing University), Cong Zhang(Chongqing University), Ya Wang(Nanjing Medical University)
Cited by 233
Related Papers
Targeting the Wnt/β-catenin signaling pathway in cancer
|Journal of Hematology & Oncology|2020|1.4k
RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent
|Journal of Experimental & Clinical Cancer Research|2021|291
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
|Journal of Hematology & Oncology|2017|256
Immune mechanisms of Concanavalin A model of autoimmune hepatitis
|World Journal of Gastroenterology|2012|247
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
|Cancer Cell|2020|234